AU2002359892A1 - Efficient nucleic acid encapsulation into medium sized liposomes - Google Patents

Efficient nucleic acid encapsulation into medium sized liposomes

Info

Publication number
AU2002359892A1
AU2002359892A1 AU2002359892A AU2002359892A AU2002359892A1 AU 2002359892 A1 AU2002359892 A1 AU 2002359892A1 AU 2002359892 A AU2002359892 A AU 2002359892A AU 2002359892 A AU2002359892 A AU 2002359892A AU 2002359892 A1 AU2002359892 A1 AU 2002359892A1
Authority
AU
Australia
Prior art keywords
nucleic acid
medium sized
sized liposomes
acid encapsulation
efficient nucleic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002359892A
Inventor
Xingong Li
Paul R. Meers
Walter R. Perkins
Shangguan Tong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Elan Pharmaceuticals LLC
Original Assignee
Elan Pharmaceuticals LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elan Pharmaceuticals LLC filed Critical Elan Pharmaceuticals LLC
Publication of AU2002359892A1 publication Critical patent/AU2002359892A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
AU2002359892A 2001-12-31 2002-12-31 Efficient nucleic acid encapsulation into medium sized liposomes Abandoned AU2002359892A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34325101P 2001-12-31 2001-12-31
US60/343,251 2001-12-31
PCT/US2002/041814 WO2003057190A1 (en) 2001-12-31 2002-12-31 Efficient nucleic acid encapsulation into medium sized liposomes

Publications (1)

Publication Number Publication Date
AU2002359892A1 true AU2002359892A1 (en) 2003-07-24

Family

ID=23345320

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002359892A Abandoned AU2002359892A1 (en) 2001-12-31 2002-12-31 Efficient nucleic acid encapsulation into medium sized liposomes

Country Status (2)

Country Link
AU (1) AU2002359892A1 (en)
WO (1) WO2003057190A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1948674A4 (en) 2005-11-02 2009-02-04 Protiva Biotherapeutics Inc Modified sirna molecules and uses thereof
AU2008342535B2 (en) 2007-12-27 2015-02-05 Arbutus Biopharma Corporation Silencing of polo-like kinase expression using interfering RNA
WO2009129319A2 (en) 2008-04-15 2009-10-22 Protiva Biotherapeutics, Inc. Silencing of csn5 gene expression using interfering rna
PT104158B (en) 2008-08-18 2011-02-24 Univ Do Minho APPLICATION OF MONOOLEÍNA AS NEW ADJUVANT LIPID IN LIPOFECTION
JP2013530187A (en) 2010-06-17 2013-07-25 ザ ユナイテッド ステイツ オブ アメリカ アズ リプレゼンティッド バイ ザ シークレタリー デパートメント オブ ヘルス アンド ヒューマン サービシーズ Compositions and methods for treating inflammatory diseases.
WO2012106490A1 (en) 2011-02-03 2012-08-09 The Government Of The U.S.A., As Represented By The Secretary, Department Of Health & Human Services Multivalent vaccines for rabies virus and filoviruses
AU2012340086A1 (en) 2011-11-17 2014-05-29 The Regents Of The University Of California Therapeutic RNA switches compositions and methods of use
US9035039B2 (en) 2011-12-22 2015-05-19 Protiva Biotherapeutics, Inc. Compositions and methods for silencing SMAD4
JP2015513535A (en) 2012-02-21 2015-05-14 アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル TIM receptor as a viral entry cofactor
IN2014DN07022A (en) 2012-02-21 2015-04-10 Inst Nat Sante Rech Med
WO2014016152A1 (en) 2012-07-27 2014-01-30 Institut National De La Sante Et De La Recherche Medicale Cd147 as receptor for pilus-mediated adhesion of meningococci to vascular endothelia
ES2813340T3 (en) 2012-09-21 2021-03-23 Intensity Therapeutics Inc Cancer treatment method
WO2016054421A1 (en) 2014-10-02 2016-04-07 Protiva Biotherapeutics, Inc Compositions and methods for silencing hepatitis b virus gene expression
WO2016164827A1 (en) 2015-04-09 2016-10-13 Bikanta Corporation Imaging systems and methods using fluorescent nanodiamonds
WO2016197132A1 (en) 2015-06-04 2016-12-08 Protiva Biotherapeutics Inc. Treating hepatitis b virus infection using crispr
US20180208932A1 (en) 2015-07-29 2018-07-26 Arbutus Biopharma Corporation Compositions and methods for silencing hepatitis b virus gene expression
JP7071933B2 (en) 2016-02-25 2022-05-19 アプライド バイオロジカル ラボラトリーズ インコーポレイテッド Compositions and methods for protection against airborne pathogens and irritants
US20170360815A1 (en) 2016-02-25 2017-12-21 Applied Biological Laboratories, Inc. Compositions and methods for protecting against airborne pathogens and irritants
WO2017176596A1 (en) 2016-04-04 2017-10-12 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Multivalent vaccines for rabies virus and coronaviruses
WO2019101882A1 (en) 2017-11-23 2019-05-31 INSERM (Institut National de la Santé et de la Recherche Médicale) New method for treating dengue virus infection

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5741513A (en) * 1990-02-08 1998-04-21 A. Natterman & Cie. Gmbh Alcoholic aqueous gel-like phospholipid composition, its use and topical preparations containing it
US5980935A (en) * 1996-05-15 1999-11-09 Kirpotin; Dmitri Cationic lipids and methods of use therefor

Also Published As

Publication number Publication date
WO2003057190A1 (en) 2003-07-17

Similar Documents

Publication Publication Date Title
AU2002359892A1 (en) Efficient nucleic acid encapsulation into medium sized liposomes
AU2002325538A1 (en) Nucleic acid amplification methods
AU2002314693A1 (en) Nucleic acid amplification method
AU2002245184A1 (en) Nucleic acid amplification
AU2002257076A1 (en) Nucleic acid shuffling
AU2001273548A1 (en) Photoselection of nucleic acid ligands
WO2003018621A8 (en) Genes
AU2001295732A1 (en) Concatenated nucleic acid sequences
AU2001240743A1 (en) Novel dna chips
AU2001293336A1 (en) Nucleic acid detection medium
AU2002234235A1 (en) Sectional drive system
AU2002258502A1 (en) Nucleic acid labeling compounds
AU2001242625A1 (en) Gene sequence
AU2001264247A1 (en) GASC1 gene
AU2001253001A1 (en) Non-pcr based recombination of nucleic acids
AU2002323437A1 (en) Gene identification
AU2002366435A1 (en) Nucleic acid amplification
AU2002310296A1 (en) Rna purification methods
AUPQ749100A0 (en) New epilespy gene
AU2001252390A1 (en) Nucleic acid immunization
AU2001285743A1 (en) Adipose-related gene
AU2002347346A1 (en) Dna vaccine
AU2002367321A1 (en) Efficient liposomal encapsulation
AU2001238440A1 (en) Hybrid nucleic acid assembly
AUPR975301A0 (en) Nucleic acid sequence

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase